Top compounds associated with response to CTD-2313N18.7


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA JW-74 CTRPv2 pan-cancer AAC 0.16 0.0006
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA FK866 CTRPv2 pan-cancer AAC 0.14 0.0006
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0007
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.13 0.0007
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0008
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0009
Download CSV